Why GERD is a Critical Differential for ACS
GERD must be considered an essential differential diagnosis for ACS because chest pain from gastroesophageal reflux can be clinically indistinguishable from cardiac ischemia, and among patients presenting with suspected ACS, 10-20% actually have a gastrointestinal cause, with GERD being the most common. 1
Clinical Overlap and Diagnostic Challenge
The symptom profiles of GERD and ACS overlap substantially, creating diagnostic difficulty:
- Pain characteristics: GERD-related chest pain can mimic myocardial ischemia with squeezing or burning sensations, lasting minutes to hours, often occurring after meals or at night, and worsening with stress 1
- Indistinguishable presentations: In one study of patients with confirmed coronary artery disease, GERD-related pain was sometimes mistaken for angina, and patients could not reliably distinguish between the two 2, 3
- High prevalence in cardiac populations: Among patients admitted to coronary care units with suspected ACS who undergo angiography, 23% show no detectable coronary abnormality, and among these, gastroesophageal diseases account for approximately 30% of cases 4
Magnitude of the Problem
The clinical significance is substantial:
- Frequency: In patients with recurrent chest pain despite negative cardiac workup, 50-64% demonstrate abnormal gastroesophageal reflux 5
- Coexistence: Even in patients with proven coronary disease and persistent symptoms despite optimal antianginal therapy, 67% have some chest pain episodes secondary to acid reflux 2
- Missed diagnoses: Historically, 2-8% of emergency department patients were inappropriately discharged with missed ACS diagnoses, making accurate differentiation critical 6
Key Distinguishing Features (Though Imperfect)
While no single feature is diagnostic, certain clues suggest GERD over ACS 1:
- Heartburn, regurgitation, or dysphagia
- Relief with antacids or antisecretory agents
- Use of medications that can cause esophagitis (NSAIDs, potassium supplements, iron, bisphosphonates)
- Absence of traditional cardiac risk factors 4
However, these symptoms are not sufficiently specific to be fully diagnostic 1, which is why GERD remains a critical consideration even after initial evaluation.
Clinical Approach When Cardiac Causes Are Excluded
When ACS is ruled out through negative stress testing, anatomic cardiac evaluation, or low-risk designation by chest pain decision pathways, evaluation for GERD becomes reasonable 1:
- First-line approach: Trial of empiric acid suppression therapy for 8 weeks 1
- If alarm symptoms present (dysphagia, odynophagia, GI bleeding, unexplained iron deficiency anemia, weight loss, recurrent vomiting): Upper endoscopy within 2 weeks 1
- If symptoms persist despite acid suppression: Consider esophageal function testing and pH monitoring 1
Important Caveats
- Vasospastic angina connection: Patients with a history of GERD have 7.8 times higher odds of having vasospastic angina, suggesting potential mechanistic links 7
- Medication effects: Nitrate therapy for cardiac disease can worsen GERD by relaxing the lower esophageal sphincter 3
- Simultaneous occurrence: Approximately 5% of chest pain episodes may be associated with both acid reflux AND cardiac ischemia simultaneously 2, 3
The bottom line: GERD is not just a diagnosis of exclusion but an active differential that must be systematically considered in any chest pain evaluation, as missing either diagnosis carries significant morbidity and mortality implications.